Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor

Ectopic ACTH syndrome (EAS) arising years after the diagnosis of a neuroendocrine tumor (NET) is exceedingly rare. We describe a case of EAS occurring five years after the diagnosis of a metastatic lung NET in a 61-year-old woman. She presented with severe hypokalemia but was not overtly Cushingoid...

Full description

Saved in:
Bibliographic Details
Main Authors: Minghao Liu, Diane Hamele-Bena, John Ausiello, Gabrielle Page-Wilson
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/6583467
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561229807222784
author Minghao Liu
Diane Hamele-Bena
John Ausiello
Gabrielle Page-Wilson
author_facet Minghao Liu
Diane Hamele-Bena
John Ausiello
Gabrielle Page-Wilson
author_sort Minghao Liu
collection DOAJ
description Ectopic ACTH syndrome (EAS) arising years after the diagnosis of a neuroendocrine tumor (NET) is exceedingly rare. We describe a case of EAS occurring five years after the diagnosis of a metastatic lung NET in a 61-year-old woman. She presented with severe hypokalemia but was not overtly Cushingoid on exam. Serum cortisol was 61mcg/dL after an overnight 1mg dexamethasone suppression test (<1.8mcg/dL) and urinary free cortisol was 7544 mcg/24h (<45mcg/24h), establishing the diagnosis of Cushing’s syndrome. Plasma levels of peptides which have been associated with EAS, Agouti-related peptide (AgRP) and the ACTH precursors POMC (31-kDa) and pro-ACTH (22-kDa), were elevated. Metyrapone was initiated, but hypercortisolism persisted and the patient succumbed to pneumonia shortly after presentation. Retrospective examination of biopsy tissues showed rare ACTH immunoreactivity at the time of initial diagnosis, followed by staining in a greater proportion of cells as the disease progressed, consistent with EAS arising years after the diagnosis of NET. Given the increase in mortality associated with EAS, this unusual case highlights the importance of early detection and raises the possibility that early immunohistochemical stains for ACTH and measurements of ACTH precursors may facilitate the identification of NETs at high risk for EAS.
format Article
id doaj-art-8b8c5b5bf5234192886d8a7e3feaf68e
institution Kabale University
issn 2090-6501
2090-651X
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-8b8c5b5bf5234192886d8a7e3feaf68e2025-02-03T01:25:34ZengWileyCase Reports in Endocrinology2090-65012090-651X2019-01-01201910.1155/2019/65834676583467Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine TumorMinghao Liu0Diane Hamele-Bena1John Ausiello2Gabrielle Page-Wilson3Endocrinology Division, Department of Medicine, Columbia University Medical Center, 650 West 168th St., Room 2012, New York, NY 10032, USADepartment of Pathology and Cell Biology, Columbia University Medical Center, Physicians and Surgeons Building, Room 404, 630 W 168th St., New York, NY 10032, USAEndocrinology Division, Department of Medicine, Columbia University Medical Center, Harkness Pavilion, 9th floor, 180 Fort Washington Ave., New York, NY 10032, USAEndocrinology Division, Department of Medicine, Columbia University Medical Center, 650 West 168th St., Room 2012, New York, NY 10032, USAEctopic ACTH syndrome (EAS) arising years after the diagnosis of a neuroendocrine tumor (NET) is exceedingly rare. We describe a case of EAS occurring five years after the diagnosis of a metastatic lung NET in a 61-year-old woman. She presented with severe hypokalemia but was not overtly Cushingoid on exam. Serum cortisol was 61mcg/dL after an overnight 1mg dexamethasone suppression test (<1.8mcg/dL) and urinary free cortisol was 7544 mcg/24h (<45mcg/24h), establishing the diagnosis of Cushing’s syndrome. Plasma levels of peptides which have been associated with EAS, Agouti-related peptide (AgRP) and the ACTH precursors POMC (31-kDa) and pro-ACTH (22-kDa), were elevated. Metyrapone was initiated, but hypercortisolism persisted and the patient succumbed to pneumonia shortly after presentation. Retrospective examination of biopsy tissues showed rare ACTH immunoreactivity at the time of initial diagnosis, followed by staining in a greater proportion of cells as the disease progressed, consistent with EAS arising years after the diagnosis of NET. Given the increase in mortality associated with EAS, this unusual case highlights the importance of early detection and raises the possibility that early immunohistochemical stains for ACTH and measurements of ACTH precursors may facilitate the identification of NETs at high risk for EAS.http://dx.doi.org/10.1155/2019/6583467
spellingShingle Minghao Liu
Diane Hamele-Bena
John Ausiello
Gabrielle Page-Wilson
Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor
Case Reports in Endocrinology
title Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor
title_full Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor
title_fullStr Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor
title_full_unstemmed Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor
title_short Ectopic ACTH Syndrome Emerging 5 Years after the Diagnosis of Neuroendocrine Tumor
title_sort ectopic acth syndrome emerging 5 years after the diagnosis of neuroendocrine tumor
url http://dx.doi.org/10.1155/2019/6583467
work_keys_str_mv AT minghaoliu ectopicacthsyndromeemerging5yearsafterthediagnosisofneuroendocrinetumor
AT dianehamelebena ectopicacthsyndromeemerging5yearsafterthediagnosisofneuroendocrinetumor
AT johnausiello ectopicacthsyndromeemerging5yearsafterthediagnosisofneuroendocrinetumor
AT gabriellepagewilson ectopicacthsyndromeemerging5yearsafterthediagnosisofneuroendocrinetumor